Welcome to our dedicated page for Barrick Mining Corporation news (Ticker: B), a resource for investors and traders seeking the latest updates and insights on Barrick Mining Corporation stock.
The Barrick Mining Corporation (NYSE: B, TSX: ABX) news page on Stock Titan provides a focused view of company announcements and market-facing disclosures for one of the world’s largest gold miners. Barrick’s news flow reflects its role as a major producer of gold and copper, with operations and projects across the Americas, Africa, the Middle East, and Asia.
Investors following B stock can use this page to track key corporate updates that shape the company’s outlook. These include notices about upcoming earnings releases and webcasts, such as the announcement that Barrick will report its full year and fourth quarter 2025 results on February 5, 2026, with a live webcast and analyst question-and-answer session. Such events offer insight into production performance, costs, project progress, and capital allocation decisions.
Alongside earnings-related news, Barrick’s regulatory communications often appear in the form of press releases furnished with its Form 6-K filings. These may cover quarterly results, comparative unaudited financial statements prepared in accordance with International Financial Reporting Standards, management’s discussion and analysis, and capital management actions such as share buyback programs.
By reviewing the Barrick Mining Corporation news feed, readers can monitor how the company reports on its gold and copper production profile, reserve base, and key projects like the Lumwana expansion and the Reko Diq copper and gold development. Bookmark this page to quickly access the latest Barrick announcements, scheduled results dates, and other official disclosures that inform analysis of the B stock.
Crawford & Company (NYSE: A) named Jemin Thakkar global chief information officer, effective April 1, 2026. Thakkar will report to President & CEO Bruce Swain and lead Crawford’s global IT and technology organization, expanding his prior role as chief information security officer.
The reorganization centralizes IT governance, aims to improve data integration and analytics, clarify accountability for technology investments, accelerate enterprise modernization, and responsibly advance AI with disciplined data and security practices.
Cereno Scientific (NASDAQ First North: B) reported initial 12-month Expanded Access Program (EAP) learnings for lead candidate CS1 in pulmonary arterial hypertension (PAH). The EAP enrolled 10 patients; CS1 was well tolerated with no unexpected safety concerns or deaths, and no discontinuations reported as related to CS1.
Six of ten patients completed 12 months; two discontinued after atrial fibrillation events assessed as not related, one withdrew consent and one was lost to follow-up. Phase IIa (25 patients, 3 months) met primary safety and tolerability endpoint with no drug-related serious adverse events. Phase IIb enrollment anticipated June 2026; further EAP analyses due Q2 2026.
BioArctic (Nasdaq: B) announces the Nomination Committee's proposals for the Annual General Meeting on May 28, 2026. The committee proposes an eight-member board, re-electing Eugen Steiner as chair and six existing members, and adding Philip Scheltens and Linda Nilsson as new board members.
Pär Gellerfors has declined re-election; Linda Nilsson is proposed to represent the Gellerfors family's holding company. The Nomination Committee members represent ~57% of shares and ~83% of votes.
Hexagon (B) will propose a distribution and listing of Octave Intelligence plc at its AGM on 24 April 2026, where ten Hexagon shares entitle holders to one Octave share. Octave Class B shares are expected to list on Nasdaq New York, with SDRs listed on Nasdaq Stockholm for about two years.
An indicative timetable sets the record date for the distribution on 22 May 2026 and first NY trading on 28 May 2026. Octave will file an amended Form 10 and host an Investor Day on 26 March 2026.
Crawford & Company (NYSE:A) named W. Bruce Swain Jr. president and chief executive officer, effective immediately on March 23, 2026.
Swain served as interim CEO since January 1, 2026, has more than three decades at Crawford including 19 years as CFO, and will remain on the board. Jesse Crawford Sr. will not stand for reelection at the Annual Shareholder Meeting on May 14, 2026, and will become an honorary board member and emeritus officer after the ASM.
BioArctic (NASDAQ: B) reported new data presented at AD/PD 2026 on long-term, real-world IV lecanemab treatment persistence and additional company presentations. Real-world claims analysis showed 78.4% persistence at 18 months, 71.7% at 20 months and 67.3% at 24 months. BioArctic also presented data on lecanemab binding to soluble Aβ protofibrils and a poster on exidavnemab trial screening using alpha-synuclein SAA. The release notes investigational status and no guarantee of regulatory approval.
Cereno Scientific (NASDAQ: B) received Swedish Medical Products Agency approval to start a Phase I pharmacokinetic study of CS014, designed using FDA pre-IND feedback. The open-label, randomized, two-period crossover trial in 14 healthy adults compares seven-day repeat dosing of CS014 versus valproic acid to characterize total and unbound plasma concentrations at steady state.
The company says a successful PK study could remove the need for additional nonclinical safety work and a Phase IIa trial, supporting a capital-efficient path toward a planned Phase II study in PH-ILD in Q1 2027. Results are expected mid-2026.
Contractor Connection (NYSE:A) announced a strategic partnership with Helixco to integrate Helixco’s time-and-materials validation platform into Contractor Connection’s commercial managed repair program. The partnership aims to add real-time transparency, standardized workflows, auditable documentation and improved billing accuracy across commercial repair projects.
The collaboration pairs Helixco’s validation technology with Contractor Connection’s credentialed contractor network to support consistency, accountability and more predictable commercial repair outcomes for carrier partners and contractors.
Hexagon (NYSE:B) released the Robot Generation study across nine markets and 18,000 participants on March 10, 2026. The research finds robot anxiety is highest where robots are least visible (UK 52%) and lowest in high-exposure markets (South Korea 29%). Security is the top worry (51%). The study links visibility, clear purpose, and control to greater public trust and notes strong comfort with robots in factories and for dangerous tasks.
BioArctic (Nasdaq Stockholm: B) issued 78,000 Class B shares in February 2026 under the 2019/2028 stock option program. As of February 27, 2026 the company had 88,719,485 shares: 74,319,489 listed Class B and 14,399,996 unlisted Class A. A shares carry ten votes; B shares carry one vote, giving a total of 218,319,449 votes.
Contact details for investor relations are provided for further inquiries.